Relationships between Inflammation, Adiponectin, and Oxidative Stress in Metabolic Syndrome

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Chen, Shu Ju ^a   Yen, Chi Hua ^b,c   Huang, Yi Chia ^b,c   Lee, Bor Jen ^c,d   Hsia, Simon ^e   Lin, Ping Ting ^b,c  

^a CHUNG CHOU UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^d TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^e HUNGKUANG UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; CATALASE; GLUTATHIONE PEROXIDASE; INTERLEUKIN 6; MALONALDEHYDE; SUPEROXIDE DISMUTASE;

ADULT; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE MARKER; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; FEMALE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OXIDATIVE STRESS; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; RISK FACTOR;

ADIPONECTIN; BIOLOGICAL MARKERS; HUMANS; INFLAMMATION; METABOLIC SYNDROME X; OXIDATIVE STRESS;

EID: 84866552703     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0045693     Document Type: Article

References (30)

1. Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (2001) Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 285: 2486-2497.
2. Ferrannini E, Haffner SM, Mitchell BD, Stern MP, (1991) Hyperinsulinaemia: the key feature of a cardiovascular and metabolic syndrome. Diabetologia 34: 416-422.
3. Ford ES, Giles WH, (2003) A comparison of the prevalence of the metabolic syndrome using two proposed definitions. Diabetes Care 26: 575-581.
4. Park YW, Zhu S, Palaniappan L, Heshka S, Carnethon MR, et al. (2003) The metabolic syndrome: prevalence and associated risk factor findings in the U.S. population from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med 163: 427-436.
5. Kolovou GD, Anagnostopoulou KK, Salpea KD, Mikhailidis DP, (2007) The prevalence of metabolic syndrome in various populations. Am J Med Sci 333: 362-371.
6. Yeh CJ, Chang HY, Pan WH, (2011) Time trend of obesity, the metabolic syndrome and related dietary pattern in Taiwan: from NAHSIT 1993-1996 to NAHSIT 2005-2008. Asia Pac J Clin Nutr 20: 292-300.
7. Ceriello A, Quatraro A, Giugliano D, (1993) Diabetes mellitus and hypertension: the possible role of hyperglycaemia through oxidative stress. Diabetologia 36: 265-266.
8. Giugliano D, Ceriello A, Paolisso G, (1995) Diabetes mellitus, hypertension, and cardiovascular disease: which role for oxidative stress? Metabolism 44: 363-368.
9. West IC, (2000) Radicals and oxidative stress in diabetes. Diabetic Med 17: 171-180.
10. Antoniades C, Tousoulis D, Tentolouris C, Toutouzas P, Stefanadis C, (2003) Oxidative stress, antioxidant vitamins, and atherosclerosis. From basic research to clinical practice. Herz 28: 628-638.
11. Stocker R, Keaney JF, (2004) Role of oxidative modification in atherosclerosis. Physiol 84: 1381-1478.
12. Penckofer S, Schwertz D, Florczak K, (2002) Oxidative stress cardiovascular disease in type 2 diabetes: the role of antioxidants and pro-oxidants. J Cardiovasc Nurs 16: 68-85.
13. Giugliano D, (2000) Dietary antioxidants for cardiovascular disease prevention. Nutr Metab Cardiovasc Dis 10: 38-44.
14. Dandona P, Aljada A, Chaudhuri A, Mohanty P, Garg R, (2005) Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation. Circulation 111: 1448-1454.
15. Luc G, Bard JM, Juhan-Vague I, Ferrieres J, Evans A, et al. (2003) C-reactive protein, interleukin-6, and fibrinogen as predictors of coronary heart disease: the PRIME Study. Arterioscler Thromb Vasc Biol 23: 1255-1261.
16. Heinrich PC, Castell JV, Andus T, (1990) Interleukin-6 and the acute phase response. Biochem J 265: 621-636.
17. Bataille R, Klein B, (1992) C-reactive protein levels as a direct indicator of interleukin-6 levels in humans in vivo. Arthritis Rheum 35: 982-984.
18. Matsuzawa Y, Funahashi T, Kihara S, Shimomura I, (2004) Adiponectin and Metabolic Syndrome. Arterioscler Thromb Vasc Biol 24: 29-33.
19. Das UN, (2004) Metabolic syndrome X: an inflammatory condition? Curr Hypertens Rep 6: 66-73.
20. Choi KM, Ryu OH, Lee KW, Kim HY, Seo JA, et al. (2007) Serum adiponectin, interleukin-10 levels and inflammatory markers in the metabolic syndrome. Diabetes Res Clin Pract 75: 235-240.
21. Lapenna D, Ciofani G, Pierdomenico SD, Giamberardino MA, Cuccurullo F, (2001) Reaction conditions affecting the relationship between thiobarbituric acid reactivity and lipid peroxides in human plasma. Free Radic Biol Med 31: 331-335.
22. Paglia D, Valentine W, (1967) Studies on the qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 70: 159-169.
23. Marklund S, Marklund G, (1974) Involvement of superoxide anion radical in autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem 47: 469-474.
24. Aebi H, (1984) Catalase in vitro. Methods Enzymol 105: 121-126.
25. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO 3rd, et al (2003) Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 107: 499-511.
26. Ridker PM, Rifai N, Stampfer MJ, Hennekens CH, (2000) Plasma concentration of interleukin-6 and the risk future myocardial infarction among apparently healthy men. Circulation 101: 1767-72.
27. Fröhlich M, Imhof A, Berg G, Hutchinson WL, Pepys MB, et al. (2000) Association between C-reactive protein and features of the metabolic syndrome: a population-based study. Diabetes Care 23: 1835-1839.
28. Ryo M, Nakamura T, Kihara S, Kumada M, Shibazaki S, et al. (2004) Adiponectin as a biomarker of the metabolic syndrome. Circ J 68: 975-981.
29. Karaouzene N, Merzouk H, Aribi M, Merzouk SA, Berrouiguet AY, et al. (2011) Effects of the association of aging and obesity on lipids, lipoproteins and oxidative stress biomarkers: a comparison of older with young men. Nutr Metab Cardiovasc Dis 21: 792-799.
30. Shoelson SE, Herrero L, Naaz A, (2007) Obesity, inflammation, and insulin resistance. Gastroenterology 132: 2169-2180.